Stock XFOR X4 PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions X4 Pharmaceuticals, Inc.

Equities

XFOR

US98420X1037

Real-time Estimate Cboe BZX
Other stock markets
 15:24:35 01/05/2024 BST 		5-day change 1st Jan Change
1.085 USD -3.13% Intraday chart for X4 Pharmaceuticals, Inc. -16.23% +28.87%
04-30 HC Wainwright Adjusts Price Target on X4 Pharmaceuticals to $5 From $3, Maintains Buy Rating MT
04-29 Pantherx® Rare Partner with X4 Pharmaceuticals Inc. for the Distribution of Xolremdi? (Mavorixafor), the First FDApproved Therapy Indicated for Use in Patients with Whim Syndrome CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. XFOR Stock
  4. Revisions X4 Pharmaceuticals, Inc.